Default company panoramic image
Sonogen logo

Sonogen Medical, Inc.

Sonogen is working to commercialize a next-generation ultrasonic bone growth stimulation device proven to be 30% more effective in initial POC testing.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Chevy Chase, MD, USA
  • Currency USD
  • Founded March 2020
  • Employees 3
  • Incorporation Type C-corp
  • Website sonogenmed.com

Company Summary

Sonogen has developed a new and innovative ultrasonic bone fracture diagnostics and healing device premised upon 35 years of published studies, theoretical research, and proof of concept testing. Sonogen’s patent pending acoustic signal, which is specifically optimized to accelerate bone fracture healing, will deliver faster healing, increased reliability, improved patient compliance, and real-time fracture healing feedback.

Advisors

Previous Investors